Determinants of Bladder Cancer Recurrence Study (The DETER Study)
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer, Cancer, Bladder Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/20/2019 |
| Start Date: | March 2015 |
| End Date: | March 2019 |
The purpose of this study is to learn how different lifestyle factors, such as cigarette
smoking and body weight, change after a diagnosis of bladder cancer, and how they influence
who gets a bladder cancer recurrence and who does not.
smoking and body weight, change after a diagnosis of bladder cancer, and how they influence
who gets a bladder cancer recurrence and who does not.
Inclusion Criteria:
- Patients ≥18 years old AND
- Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)
Exclusion Criteria:
- Patients are ineligible for the study if they have/had:
- Histologically-confirmed NMIBC diagnosed >36 months prior to enrollment
- Cystectomy prior to enrollment
- Any condition, which in the opinion of the primary MSK clinician or investigators
precludes their ability to provide informed consent or comply with study procedures
- Non English-speaking
We found this trial at
4
sites
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Principal Investigator: Helena Furberg-Barnes, PhD
Phone: 646-888-8246
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
500 Westchester Avenue
Harrison, New York 10604
Harrison, New York 10604
Phone: 646-888-8246
Click here to add this to my saved trials